Genufood Energy Enzymes Corp
OTC:GFOO
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.0003
0.0003
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Genufood Energy Enzymes Corp
Genufood Energy Enzymes Corp. is a shell company, which currently commencing no business operations. The company is headquartered in Arcadia, California. The company went IPO on 2012-06-05. The firm were a start-up company whose focus was to promote, market, distribute and export a range of enzyme products manufactured in the United States for sale for human and animal consumption in certain Asian markets, including the Association of Southeast Asian Nations (ASEAN). The firm is planning to engage in the business of distribution and sales of medical test kits in the United States. The firm has had made two investments in Hukui Biotechnology Corporation. The firm has not generated any revenue.
Genufood Energy Enzymes Corp. is a shell company, which currently commencing no business operations. The company is headquartered in Arcadia, California. The company went IPO on 2012-06-05. The firm were a start-up company whose focus was to promote, market, distribute and export a range of enzyme products manufactured in the United States for sale for human and animal consumption in certain Asian markets, including the Association of Southeast Asian Nations (ASEAN). The firm is planning to engage in the business of distribution and sales of medical test kits in the United States. The firm has had made two investments in Hukui Biotechnology Corporation. The firm has not generated any revenue.
